Sino-US United MetLife Insurance

Sino-US United MetLife Insurance

The firm was established in 2005 as a joint venture between subsidiaries of MetLife, Inc. and Shanghai Alliance Investment Ltd. (SAIL), an investment entity overseen by the Shanghai National Capital Bureau. The fifty-fifty ownership split structures MetLife's onshore China life insurance operations — the parent contributes actuarial and distribution expertise while SAIL provides local regulatory standing and access to domestic infrastructure flows. The vehicle sells life, health, accidental injury, and annuity products to consumers across more than twenty Chinese cities. Asset allocation flows from the general account and separate-account investment-linked insurance funds into China's onshore equity and fixed-income markets, supplemented by physical real estate. The commercial and agricultural real estate portfolio holds mixed-use assets inside China. As an insurance company, the firm does not operate as a third-party asset manager but deploys premiums against actuarial liabilities — a posture that confines the portfolio to domestic regulators' prescribed investment baskets. Policyholder capital enters via a multi-channel distribution network that includes agency managers and, notably, strong participation in the Million Dollar Round Table, a global association of high-contact life insurance producers. The firm participates in the Asia-Pacific LIMRA distribution conferences, providing a named window into its agent-development bench. The joint venture supports the Little Pearl Student-Aid Program, a philanthropic vehicle that separates mission-oriented capital from underwriting reserves. Agent productivity and MDRT membership form the cultural core of the distribution organization, though the number of licensed agents and total in-force premiums remains undisclosed. No recent dated operational event — such as a CEO change or regulatory milestone — is available from primary public sources as of 2026. The joint venture's architecture produces a distinct regulatory outcome: an American insurance group cannot write onshore China life policies directly, but a fifty-fifty JV with a state-owned partner can. The structure turns MetLife into a capital markets asset allocator inside China's domestic insurance framework — an arrangement that mirrors how other foreign insurers access the Chinese market but tethers the firm's investment committee to SAIL's dual mandate of commercial viability and state-aligned capital deployment.